Literature DB >> 16806848

Gata3 is required for early morphogenesis and Fgf10 expression during otic development.

Kersti Lilleväli1, Maarja Haugas, Tanja Matilainen, Christel Pussinen, Alar Karis, Marjo Salminen.   

Abstract

Inner ear develops from an induced surface ectoderm placode that invaginates and closes to form the otic vesicle, which then undergoes a complex morphogenetic process to form the membranous labyrinth. Inner ear morphogenesis is severely affected in Gata3 deficient mouse embryos, but the onset and basis of the phenotype has not been known. We show here that Gata3 deficiency leads to severe and unique abnormalities during otic placode invagination. The invagination problems are accompanied often by the formation of a morphological boundary between the dorsal and ventral otic cup and by the precocious appearance of dorsal endolymphatic characteristics. In addition, the endolymphatic domain often detaches from the rest of the otic epithelium during epithelial closure. The expression of several cell adhesion mediating genes is altered in Gata3 deficient ears suggesting that Gata3 controls adhesion and morphogenetic movements in early otic epithelium. Inactivation of Gata3 leads also to a loss of Fgf10 expression in otic epithelium and auditory ganglion demonstrating that Gata3 is an important regulator of Fgf-signalling during otic development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16806848     DOI: 10.1016/j.mod.2006.04.007

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  33 in total

1.  Otic ablation of smoothened reveals direct and indirect requirements for Hedgehog signaling in inner ear development.

Authors:  Alexander S Brown; Douglas J Epstein
Journal:  Development       Date:  2011-08-10       Impact factor: 6.868

2.  Notch signaling augments the canonical Wnt pathway to specify the size of the otic placode.

Authors:  Chathurani S Jayasena; Takahiro Ohyama; Neil Segil; Andrew K Groves
Journal:  Development       Date:  2008-05-21       Impact factor: 6.868

3.  Transcription factor Isl1 is dispensable for the development of the mouse prosensory region.

Authors:  Daqiang He; Rui Guo; Dongwang Zheng; Mei Xu; Ping Li; Luming Guo; Lin Gan
Journal:  Cytotechnology       Date:  2020-03-26       Impact factor: 2.058

Review 4.  Setting appropriate boundaries: fate, patterning and competence at the neural plate border.

Authors:  Andrew K Groves; Carole LaBonne
Journal:  Dev Biol       Date:  2013-12-07       Impact factor: 3.582

5.  Gata3 is a critical regulator of cochlear wiring.

Authors:  Jessica M Appler; Cindy C Lu; Noah R Druckenbrod; Wei-Ming Yu; Edmund J Koundakjian; Lisa V Goodrich
Journal:  J Neurosci       Date:  2013-02-20       Impact factor: 6.167

6.  Lmx1a is required for segregation of sensory epithelia and normal ear histogenesis and morphogenesis.

Authors:  David H Nichols; Sarah Pauley; Israt Jahan; Kirk W Beisel; Kathleen J Millen; Bernd Fritzsch
Journal:  Cell Tissue Res       Date:  2008-11-05       Impact factor: 5.249

7.  Continued expression of GATA3 is necessary for cochlear neurosensory development.

Authors:  Jeremy S Duncan; Bernd Fritzsch
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

8.  Comprehensive Wnt-related gene expression during cochlear duct development in chicken.

Authors:  Ulrike J Sienknecht; Donna M Fekete
Journal:  J Comp Neurol       Date:  2008-10-01       Impact factor: 3.215

9.  Downstream targets of GATA3 in the vestibular sensory organs of the inner ear.

Authors:  David M Alvarado; Rose Veile; Judith Speck; Mark Warchol; Michael Lovett
Journal:  Dev Dyn       Date:  2009-12       Impact factor: 3.780

10.  Genomic analysis of the function of the transcription factor gata3 during development of the mammalian inner ear.

Authors:  Marta Milo; Daniela Cacciabue-Rivolta; Adam Kneebone; Hikke Van Doorninck; Claire Johnson; Grace Lawoko-Kerali; Mahesan Niranjan; Marcelo Rivolta; Matthew Holley
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.